These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 1358620

  • 1. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects.
    Mattila MJ, Kuitunen T, Plétan Y.
    Eur J Clin Pharmacol; 1992; 43(2):179-84. PubMed ID: 1358620
    [Abstract] [Full Text] [Related]

  • 2. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
    Mattila MJ, Aranko K, Kuitunen T.
    Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
    [Abstract] [Full Text] [Related]

  • 3. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, Rhodes G.
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [Abstract] [Full Text] [Related]

  • 4. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R, García-Gea C, Puntes M, Pérez J, Esbrí R, Serra C, Fortea J, Barbanoj MJ.
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
    Yamaguchi T, Hashizume T, Matsuda M, Sakashita M, Fujii T, Sekine Y, Nakashima M, Uematsu T.
    Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
    [Abstract] [Full Text] [Related]

  • 6. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
    Vincent J, Sumner DJ, Reid JL.
    Br J Clin Pharmacol; 1988 Nov; 26(5):503-8. PubMed ID: 2905151
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ, Preston RA, Swan SK.
    Clin Pharmacokinet; 2007 Nov; 46(6):525-34. PubMed ID: 17518511
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.
    Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ.
    Clin Pharmacokinet; 2004 Nov; 43(2):121-9. PubMed ID: 14748620
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY, Argenti D, Wilson J, Garcia J, Heald D.
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [Abstract] [Full Text] [Related]

  • 10. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J, Schoemaker HC, Bruno R, Reinhoudt JF, Breimer DD, Cohen AF.
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [Abstract] [Full Text] [Related]

  • 11. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P, Gillen MS, Malik M, Pentikis H, Rhodes GR, Roberts DJ.
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J, Liminana R, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1988 Nov; 26(5):497-502. PubMed ID: 2905150
    [Abstract] [Full Text] [Related]

  • 13. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch, Shamsi Z.
    Curr Med Res Opin; 2001 Nov; 17(4):273-81. PubMed ID: 11922401
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M, Sakashita M, Mizuki Y, Yamaguchi T, Fujii T, Sekine Y.
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [Abstract] [Full Text] [Related]

  • 15. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA, De Vries G, De Waard D.
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
    Frank H, Gillen M, Rohatagi SS, Lim J, George G, Ebastine Study Group.
    J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
    Puigdemont A, Queralt M, Jansat JM, Martinez-Tobed A.
    J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390
    [Abstract] [Full Text] [Related]

  • 18. Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG.
    Hopes H, Meuret GH, Ungethüm W, Leopold G, Wiemann H.
    Eur J Clin Pharmacol; 1992 Jul; 42(1):55-9. PubMed ID: 1347267
    [Abstract] [Full Text] [Related]

  • 19. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 20. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
    Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K.
    Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.